COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey.

Jolanda SabatinoPaolo FerreroMassimo ChessaFrancesco BiancoPaolo CilibertiAurelio SecinaroLilia OretoMartina AvesaniValentina BucciarelliGiuseppe CalcaterraMaria Pia CalabròMaria Giovanna RussoPier Paolo BassareoPaolo GuccioneCiro IndolfiGiovanni Di Salvo

Published in: Journal of clinical medicine (2020)

Despite previous reports pointing to a higher case-fatality rate among patients with cardiovascular co-morbidities, we observed a mild COVID-19 clinical course in our cohort of CHD patients. Although these results should be confirmed in larger cohorts to investigate the underlying mechanisms, the findings of low cardiovascular complications rates and no deaths are reassuring for CHD patients.

Keyphrases

end stage renal disease
congenital heart disease
coronavirus disease
ejection fraction
newly diagnosed
sars cov
chronic kidney disease
prognostic factors
peritoneal dialysis
emergency department
patient reported
respiratory syndrome coronavirus